May endocan be a new biomarker in the diagnosis of endometriosis?

Creative Commons License

Cimilli Şenocak G. N., Yapça Ö. E., Topdağı Yılmaz E. P., Öztürk N., Ozdes S., Kumtepe Y.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, cilt.51, sa.7, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.jogoh.2022.102423
  • Dergi Adı: JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Endocan, Endometriosis, Biomarker, PATHOPHYSIOLOGY, PATHOGENESIS, SERUM, PAIN
  • Atatürk Üniversitesi Adresli: Evet

Özet

Aim: As known, inflammatory substances are considered to have a role in the onset and progression of endometriosis. In this study, we aimed to find a biomarker that can be used in the diagnosis of endometriosis by investigating the serum levels of endocan, which is a substance that we know to have an important role in angiogenesis and inflammation, in patients with endometriosis.